25th March 2024
Live Investor Briefing
Investor Q&A with Steven Yatomi-Clarke In this session Prescient Therapeutics (ASX: PTX) CEO and Managing Director Steven Yatomi-Clarke discussed the key highlights: An update on Prescient's strategy and upcoming milestones, with a focus on PTX-100. The journey of value creation for...
Speaker
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.